Intralesional Treatment of Keloids

Vitamin D in Keloids

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06729840

Enrollment

Registered

2024-12-11

Start date

2024-12-01

Completion date

2025-05-02

Last updated

2024-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scar, Hypertrophic

Keywords

keloids , vitamin D

Brief summary

Intralesional injection in treatment of keloid

Detailed description

Our study will include 45 patient diveded into three groups , follow up will done before each session , 3month after the last session using photographing assessment , scoring , dermoscope

Interventions

DRUGInjection

Vitamin D , botox , tramcinolone intralesionally injected in keloid

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Masking description

Participant doesnot know injected substance

Intervention model description

3 groups

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

Both sex aged 18-60 having keloid \-

Exclusion criteria

* pregnancy , lactation Skin disease

Design outcomes

Primary

Measure	Time frame	Description
Posas score	One session every two weeks total duration 3 months	patient and observer parameters will be assessed

Countries

Egypt

Contacts

Primary Contactsama alaa, resident doctor

samaalaa.867@gmail.com01027748791

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026